The Joint Corp. (JYNT) is a publicly traded Healthcare sector company. As of May 21, 2026, JYNT trades at $8.76 with a market cap of $124.45M and a P/E ratio of 38.15. JYNT moved +0.57% today. Year to date, JYNT is -1.69%; over the trailing twelve months it is -13.71%. Its 52-week range spans $7.50 to $13.47. Analyst consensus is neutral with an average price target of $10.00. Rallies surfaces JYNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Joint Corp Q1 Revenue Seen at $14.5M as Annual Estimates Rise: The Joint Corp is projected to report Q1 2026 revenue of $14.50 million and EPS of $0.03 while full-year 2026 revenue estimates have risen from $57.70 million to $60.40 million as earnings forecasts were trimmed to $0.21. Analysts set an average price target of $10.00 suggesting 16.3% upside.
| Metric | Value |
|---|---|
| Price | $8.76 |
| Market Cap | $124.45M |
| P/E Ratio | 38.15 |
| EPS | $0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.47 |
| 52-Week Low | $7.50 |
| Volume | 16 |
| Avg Volume | 0 |
| Revenue (TTM) | $56.64M |
| Net Income | $3.24M |
| Gross Margin | 80.62% |
4 analysts cover JYNT: 0 strong buy, 1 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $10.00.